Millicent Pharma
PrivateLast Round
Corporate Funding
May 25, 2018
Company Overview
Millicent Pharma is a specialty pharmaceutical company that develops and commercializes innovative therapies focused on women's health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Millicent Pharma Comparables
Compare Millicent Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cosette Pharmaceuticals, Inc. | 85% | |
| Theramex | 81% | |
| Insud Pharma | 79% | |
Millicent Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | May 25, 2018 |
Millicent Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bourne Partners Strategic Capital | Corporate Funding |
| The Carlyle Group | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2025
Grew 42% QoQ from 36 to 51 employees.
- May 2, 2025
Grew 21% QoQ, from 34 to 41 employees.
Millicent Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Millicent Pharma's valuation, stock price, and market status.